Hepatitis C virus nonstructural protein 3 serine protease (HCV NS3 protease)

The **Hepatitis C virus nonstructural protein 3 serine protease (HCV NS3 protease)** is a multifunctional viral enzyme crucial for viral replication, classified as a serine protease structurally related to trypsin and chymotrypsin[1][3][4][5]. Its N-terminal domain harbors the proteolytic active site responsible for cleaving and processing the viral polyprotein into functional nonstructural proteins, a step essential for viral assembly and replication[5]. The enzyme requires a zinc ion for structural stability and, in the context of HCV, partners with the NS4A cofactor for full activity[1][3]. NS3 also exhibits RNA helicase activity in its C-terminal region[5]. NS3 protease is a validated **therapeutic target** in hepatitis C infection; numerous direct-acting antivirals are designed to inhibit its enzymatic activity and thereby block viral replication[6][8]. Resistance mutations in NS3 can reduce drug efficacy[6]. The concept of targeting NS3 protease has also informed drug development for other flaviviruses (e.g., dengue virus, where NS3 similarly processes the viral polyprotein)[2][4]. Safety concerns in therapy include drug resistance and off-target effects, reflecting the enzyme’s conserved serine protease mechanism shared with other host proteins[6].

Other names

NS3 serine proteaseHCV NS3NS3/4A proteaseflaviviral NS3 protease

Reversible or covalent inhibition of serine protease catalytic activity to block viral polyprotein processing, preventing spread and replication of the virus